Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 20 de 24
Filtrer
2.
J Agric Food Chem ; 72(25): 14099-14113, 2024 Jun 26.
Article de Anglais | MEDLINE | ID: mdl-38181219

RÉSUMÉ

Cannabis is widely used for medicinal and recreational purposes. As a result, there is increased interest in its chemical components and their physiological effects. However, current information on cannabis chemistry is often outdated or scattered across many books and journals. To address this issue, we used modern metabolomics techniques and modern bioinformatics techniques to compile a comprehensive list of >6000 chemical constituents in commercial cannabis. The metabolomics methods included a combination of high- and low-resolution liquid chromatography-mass spectrometry (MS), gas chromatography-MS, and inductively coupled plasma-MS. The bioinformatics methods included computer-aided text mining and computational genome-scale metabolic inference. This information, along with detailed compound descriptions, physicochemical data, known physiological effects, protein targets, and referential compound spectra, has been made available through a publicly accessible database called the Cannabis Compound Database (https://cannabisdatabase.ca). Such a centralized, open-access resource should prove to be quite useful for the cannabis community.


Sujet(s)
Cannabis , Cannabis/composition chimique , Métabolomique , Chromatographie gazeuse-spectrométrie de masse , Extraits de plantes/composition chimique , Spectrométrie de masse , Biologie informatique
3.
Nature ; 623(7985): 71-76, 2023 Nov.
Article de Anglais | MEDLINE | ID: mdl-37604186

RÉSUMÉ

Electrochemical synthesis can provide more sustainable routes to industrial chemicals1-3. Electrosynthetic oxidations may often be performed 'reagent-free', generating hydrogen (H2) derived from the substrate as the sole by-product at the counter electrode. Electrosynthetic reductions, however, require an external source of electrons. Sacrificial metal anodes are commonly used for small-scale applications4, but more sustainable options are needed at larger scale. Anodic water oxidation is an especially appealing option1,5,6, but many reductions require anhydrous, air-free reaction conditions. In such cases, H2 represents an ideal alternative, motivating the growing interest in the electrochemical hydrogen oxidation reaction (HOR) under non-aqueous conditions7-12. Here we report a mediated H2 anode that achieves indirect electrochemical oxidation of H2 by pairing thermal catalytic hydrogenation of an anthraquinone mediator with electrochemical oxidation of the anthrahydroquinone. This quinone-mediated H2 anode is used to support nickel-catalysed cross-electrophile coupling (XEC), a reaction class gaining widespread adoption in the pharmaceutical industry13-15. Initial validation of this method in small-scale batch reactions is followed by adaptation to a recirculating flow reactor that enables hectogram-scale synthesis of a pharmaceutical intermediate. The mediated H2 anode technology disclosed here offers a general strategy to support H2-driven electrosynthetic reductions.

4.
Magn Reson Chem ; 61(12): 681-704, 2023 12.
Article de Anglais | MEDLINE | ID: mdl-37265034

RÉSUMÉ

Nuclear magnetic resonance (NMR) spectral analysis of biofluids can be a time-consuming process, requiring the expertise of a trained operator. With NMR becoming increasingly popular in the field of metabolomics, there is a growing need to change this paradigm and to automate the process. Here we introduce MagMet, an online web server, that automates the processing and quantification of 1D 1 H NMR spectra from biofluids-specifically, human serum/plasma metabolites, including those associated with inborn errors of metabolism (IEM). MagMet uses a highly efficient data processing procedure that performs automatic Fourier Transformation, phase correction, baseline optimization, chemical shift referencing, water signal removal, and peak picking/peak alignment. MagMet then uses the peak positions, linewidth information, and J-couplings from its own specially prepared standard metabolite reference spectral NMR library of 85 serum/plasma compounds to identify and quantify compounds from experimentally acquired NMR spectra of serum/plasma. MagMet employs linewidth adjustment for more consistent quantification of metabolites from higher field instruments and incorporates a highly efficient data processing procedure for more rapid and accurate detection and quantification of metabolites. This optimized algorithm allows the MagMet webserver to quickly detect and quantify 58 serum/plasma metabolites in 2.6 min per spectrum (when processing a dataset of 50-100 spectra). MagMet's performance was also assessed using spectra collected from defined mixtures (simulating other biofluids), with >100 previously measured plasma spectra, and from spiked serum/plasma samples simulating known IEMs. In all cases, MagMet performed with precision and accuracy matching the performance of human spectral profiling experts. MagMet is available at http://magmet.ca.


Sujet(s)
Imagerie par résonance magnétique , Métabolomique , Humains , Spectroscopie par résonance magnétique/méthodes , Métabolomique/méthodes , Sérum , Algorithmes
5.
Wounds ; 35(6): E186-E188, 2023 06.
Article de Anglais | MEDLINE | ID: mdl-37347593

RÉSUMÉ

There is a common belief and practice that any exposure to oral or parenteral antibiotics prior to bone biopsy makes culture results unreliable. The aim of this article was to evaluate the effect of antibiotic exposure on bacterial yield in DFO microbiology specimens. The authors retrospectively evaluated 114 patients with DFO confirmed by histology. The primary outcome measurement was the proportion of bone biopsies with positive bacterial cultures. There was no statistically significant difference in culture yield in patients who received antibiotics (77.9%) and patients who did not (85.7%, P = .58). This study demonstrates that there were no differences in bacterial yield whether antibiotics were withheld or administered before bone cultures were obtained. The duration of antibiotic use prior to bone biopsy did not change the bacterial yield.


Sujet(s)
Antibactériens , Os et tissu osseux , Humains , Études rétrospectives , Antibactériens/pharmacologie , Antibactériens/usage thérapeutique , Cytoponction/méthodes
6.
Chem Rev ; 123(9): 6233-6256, 2023 May 10.
Article de Anglais | MEDLINE | ID: mdl-36198176

RÉSUMÉ

Nonprecious metal heterogeneous catalysts composed of first-row transition metals incorporated into nitrogen-doped carbon matrices (M-N-Cs) have been studied for decades as leading alternatives to Pt for the electrocatalytic O2 reduction reaction (ORR). More recently, similar M-N-C catalysts have been shown to catalyze the aerobic oxidation of organic molecules. This Focus Review highlights mechanistic similarities and distinctions between these two reaction classes and then surveys the aerobic oxidation reactions catalyzed by M-N-Cs. As the active-site structures and kinetic properties of M-N-C aerobic oxidation catalysts have not been extensively studied, the array of tools and methods used to characterize ORR catalysts are presented with the goal of supporting further advances in the field of aerobic oxidation.

7.
Br J Radiol ; 95(1140): 20220230, 2022 Dec 01.
Article de Anglais | MEDLINE | ID: mdl-36367095

RÉSUMÉ

OBJECTIVE: Investigate the performance of multiparametric MRI radiomic features, alone or combined with current standard-of-care methods, for pulmonary nodule classification. Assess the impact of segmentation variability on feature reproducibility and reliability. METHODS: Radiomic features were extracted from 74 pulmonary nodules of 68 patients who underwent nodule resection or biopsy after MRI exam. The MRI features were compared with histopathology and conventional quantitative imaging values (maximum standardized uptake value [SUVmax] and mean Hounsfield unit [HU]) to determine whether MRI radiomic features can differentiate types of nodules and associate with SUVmax and HU using Wilcoxon rank sum test and linear regression. Diagnostic performance of features and four machine learning (ML) models were evaluated with area under the receiver operating characteristic curve (AUC) and 95% confidence intervals (CIs). Concordance correlation coefficient (CCC) assessed the segmentation variation impact on feature reproducibility and reliability. RESULTS: Elevn diffusion-weighted features distinguished malignant from benign nodules (adjusted p < 0.05, AUC: 0.73-0.81). No features differentiated cancer types. Sixty-seven multiparametric features associated with mean CT HU and 14 correlated with SUVmax. All significant MRI features outperformed traditional imaging parameters (SUVmax, mean HU, apparent diffusion coefficient [ADC], T1, T2, dynamic contrast-enhanced imaging values) in distinguishing malignant from benign nodules with some achieving statistical significance (p < 0.05). Adding ADC and smoking history improved feature performance. Machine learning models demonstrated strong performance in nodule classification, with extreme gradient boosting (XGBoost) having the highest discrimination (AUC = 0.83, CI=[0.727, 0.932]). We found good to excellent inter- and intrareader feature reproducibility and reliability (CCC≥0.80). CONCLUSION: Eleven MRI radiomic features differentiated malignant from benign lung nodules, outperforming traditional quantitative methods. MRI radiomic ML models demonstrated good nodule classification performances with XGBoost superior to three others. There was good to excellent inter- and intrareader feature reproducibility and reliability. ADVANCES IN KNOWLEDGE: Our study identified MRI radiomic features that successfully differentiated malignant from benign lung nodules and demonstrated high performance of our MR radiomic feature-based ML models for nodule classification. These new findings could help further establish thoracic MRI as a non-invasive and radiation-free alternative to standard practice for pulmonary nodule assessment.


Sujet(s)
Imagerie par résonance magnétique , Nodules pulmonaires multiples , Humains , Reproductibilité des résultats , Imagerie par résonance magnétique/méthodes , Nodules pulmonaires multiples/imagerie diagnostique , Imagerie par résonance magnétique de diffusion/méthodes , Spectroscopie par résonance magnétique , Études rétrospectives
8.
J Am Chem Soc ; 144(2): 922-927, 2022 01 19.
Article de Anglais | MEDLINE | ID: mdl-34985869

RÉSUMÉ

M-N-C catalysts, incorporating non-precious-metal ions (e.g. M = Fe, Co) within a nitrogen-doped carbon support, have been the focus of broad interest for electrochemical O2 reduction and aerobic oxidation reactions. The present study explores the mechanistic relationship between the O2 reduction mechanism under electrochemical and chemical conditions. Chemical O2 reduction is investigated via the aerobic oxidation of a hydroquinone, in which the O-H bonds supply the protons and electrons needed for O2 reduction to water. Mechanistic studies have been conducted to elucidate whether the M-N-C catalyst couples two independent half-reactions (IHR), similar to electrode-mediated processes, or mediates a direct inner-sphere reaction (ISR) between O2 and the organic molecule. Kinetic data support the latter ISR pathway. This conclusion is reinforced by rate/potential correlations that reveal significantly different Tafel slopes, implicating different mechanisms for chemical and electrochemical O2 reduction.


Sujet(s)
Cobalt/composition chimique , Fer/composition chimique , Oxygène/composition chimique , Carbone/composition chimique , Catalyse , Électrolyse/méthodes , Hydroquinones/composition chimique , Ions/composition chimique , Cinétique , Azote/composition chimique , Oxydoréduction
9.
Metabolites ; 11(5)2021 May 11.
Article de Anglais | MEDLINE | ID: mdl-34064699

RÉSUMÉ

Metabolomics plays an important role in various fields from health to agriculture. However, the comprehensive quantitative metabolomic analysis of plants and plant metabolites has not been widely performed. Liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS)-based plant metabolomics offers the sensitivity and breadth of coverage for both phenotyping and disease diagnosis of plants. Here, we report a high-coverage and quantitative MS-based assay for plant metabolite analysis. The assay detects and quantifies 206 primary and secondary plant metabolites, including many key plant hormones. In total, it measures 28 amino acids and derivatives, 27 organic acids, 20 biogenic amines and derivatives, 40 acylcarnitines, 90 phospholipids and C-6 sugars. All the analysis methods in this assay are based on LC-MS/MS techniques using both positive and negative-mode multiple reaction monitoring (MRM). The recovery rates of spiked plant samples at three different concentration levels (low, medium and high) ranged from 80% to 120%, with satisfactory precision values of less than 20%. This targeted plant metabolomic assay has been successfully applied to the analysis of large numbers of pine and spruce needle samples, canola root samples, as well as cannabis samples. Moreover, the assay was specifically developed in a 96-well plate format, which enables automated, high-throughput sample analysis. This assay has already been used to analyze over 1500 crop plant samples in less than two months.

10.
ACS Energy Lett ; 5(5): 1407-1412, 2020 May 08.
Article de Anglais | MEDLINE | ID: mdl-32856004

RÉSUMÉ

The development of processes for electrochemical energy conversion and chemical production could benefit from new strategies to interface chemical redox reactions with electrodes. Here, we employ a diffusible low-potential organic redox mediator, 9,10-anthraquinone-2,7-disulfonic acid (AQDS), to promote efficient electrochemical oxidation of H2 at an off-electrode heterogeneous catalyst. This unique approach to integrate chemical and electrochemical redox processes accesses power densities up to 228 mW/cm2 (528 mW/cm2 with iR-correction). These values are significantly higher than those observed in previous mediated electrochemical H2 oxidation methods, including those using enzymes or inorganic mediators. The approach described herein shows how traditional catalytic chemistry can be coupled to electrochemical devices.

11.
Anal Chem ; 92(15): 10627-10634, 2020 08 04.
Article de Anglais | MEDLINE | ID: mdl-32634308

RÉSUMÉ

Among all the human biological fluids used for disease biomarker discovery or clinical chemistry, urine stands out. It can be collected easily and noninvasively, it is readily available in large volumes, it is typically free from protein contamination, and it is chemically complex-reflecting a wide range of physiological states and functions. However, the comprehensive metabolomic analysis of urine has been somewhat less studied compared to blood. Indeed, most published metabolomic assays are specifically optimized for serum or plasma. In an effort to improve this situation, we have developed a comprehensive, quantitative MS-based assay for urine analysis. The assay robustly detects and quantifies 142 urinary metabolites including 28 amino acids and derivatives, 17 organic acids, 22 biogenic amines and derivatives, 40 acylcarnitines, 34 lipids, and glucose/hexose, among which 67 metabolites are absolutely quantified and 75 metabolites are semiquantified. All the analysis methods in this assay are based on liquid chromatography-tandem mass spectrometry (LC-MS/MS) using both positive and negative-mode multiple reaction monitoring (MRM). The recovery rates of spiked urine samples at three different concentration levels, that is, low, medium and high, are in the range of 80% to 120% with satisfactory precision values of less than 20%. This targeted metabolomic assay has been successfully applied to the analysis of large numbers of human urine samples, with results closely matching those reported in the literature as well as those obtained from orthogonal analysis via NMR spectroscopy. Moreover, the assay was specifically developed in a 96-well plate format, which enables automated, high-throughput sample analysis. The assay has already been used to analyze more than 1800 urine samples in our laboratory since early 2019.


Sujet(s)
Métabolomique/méthodes , Examen des urines/méthodes , Méthodes de préparation d'échantillons analytiques , Calibrage
12.
J Pharm Pract ; 32(5): 579-583, 2019 Oct.
Article de Anglais | MEDLINE | ID: mdl-29463168

RÉSUMÉ

Fluid resuscitation, to restore intravascular volume and improve oxygen delivery, is a crucial step in early resuscitation efforts of patients with sepsis or septic shock. The 2016 Surviving Sepsis Campaign guidelines suggest the use of dynamic versus static measures of fluid responsiveness and fluid resuscitation with at least 30 mL/kg of intravenous crystalloid within the first 3 hours followed by fluid administration if hemodynamic factors continue to improve. Despite these recommendations, risks to this practice may exist as multiple studies have demonstrated an association between a positive fluid balance and/or administration of large fluid volume and increase in mortality. These studies are limited by variations in their methodologic design; therefore, cause and effect cannot yet be determined. Future multicenter, randomized, controlled studies that evaluate fluid balance and fluid volume need to be conducted to clarify the role of fluid administration to patients with sepsis to maximize benefits and minimize risk.


Sujet(s)
Cristalloïdes/administration et posologie , Traitement par apport liquidien/mortalité , Réanimation/mortalité , Réanimation/méthodes , Sepsie/mortalité , Sepsie/thérapie , Administration par voie intraveineuse , Cristalloïdes/effets indésirables , Traitement par apport liquidien/effets indésirables , Humains , Mortalité/tendances , Réanimation/effets indésirables
13.
J Surg Oncol ; 118(3): 431-439, 2018 Sep.
Article de Anglais | MEDLINE | ID: mdl-30076741

RÉSUMÉ

BACKGROUND AND OBJECTIVES: Hepatocellular carcinoma (HCC) in patients with hepatitis B virus (HBV) exhibit lower tumor microRNA-26a (miR-26a) expression which is associated with worse outcomes. It is unknown if similar miR-26a loss occurs in HCC developed in other liver diseases. We examined tumor miR-26a expression and its impact on recurrence and mortality in a North American HCC cohort. METHODS: MiR-26a levels from tumor and surrounding nontumor liver tissue in 186 subjects were collected. We defined lower tumor expression of miR-26a as <1-fold that of the adjacent nontumor liver tissue. RESULTS: Viral hepatitis (42%; 40% hepatitis C and 2% HBV), alcohol (19%), and nonalcoholic fatty liver disease (NAFLD) (18%) were the most common causes of liver disease. The prevalence of lower tumor miR-26a expression was 68%, and it was evident in HCCs arising in all etiologies (viral hepatitis 60%, alcohol 61%, and NAFLD 76%). Subjects with lower tumor miR-26a expression had significantly higher tumor recurrence (hazard ratio [HR], 2.45; 95% confidence interval [CI], 1.18 to 5.1; P = 0.016) and higher mortality of borderline significance (HR, 1.51; 95% CI, 0.94 to 2.41; P = 0.086). CONCLUSION: Reduced miR-26a expression is a common phenomenon in HCC arising in North American patients with different underlying liver diseases and may increase recurrence and mortality after surgery.


Sujet(s)
Marqueurs biologiques tumoraux/sang , Carcinome hépatocellulaire/chirurgie , Régulation de l'expression des gènes tumoraux , Hépatectomie/méthodes , Tumeurs du foie/chirurgie , microARN/sang , Récidive tumorale locale/sang , Sujet âgé , Marqueurs biologiques tumoraux/génétique , Carcinome hépatocellulaire/anatomopathologie , Femelle , Études de suivi , Humains , Tumeurs du foie/anatomopathologie , Mâle , microARN/génétique , Adulte d'âge moyen , Récidive tumorale locale/diagnostic , Récidive tumorale locale/génétique , Pronostic , Transduction du signal , Taux de survie
14.
Annu Int Conf IEEE Eng Med Biol Soc ; 2017: 2498-2501, 2017 Jul.
Article de Anglais | MEDLINE | ID: mdl-29060406

RÉSUMÉ

Neural prostheses have generally relied on signals from cortical motor regions to control reaching movements of a robotic arm. However, little work has been done in exploring the involvement of nonmotor cortical and associative regions during motor tasks. In this study, we identify regions which may encode direction during planning and movement of a center-out motor task. Local field potentials were collected using stereoelectroencephalography (SEEG) from nine epilepsy patients implanted with multiple depth electrodes for clinical purposes. Spectral analysis of the recorded data was performed using nonparametric statistical techniques to identify regions that may encode direction of movements during the motor task. The analysis revealed several nonmotor regions; including the right insular cortex, right temporal pole, right superior parietal lobule, and the right lingual gyrus, that encode directionality before and after movement onset. We observed that each of these regions encode direction in different frequency bands. This preliminary study suggests that nonmotor regions may be useful in assisting in neural prosthetic control.


Sujet(s)
Encéphale , Cartographie cérébrale , Épilepsie , Humains , Mouvement
15.
Front Neural Circuits ; 11: 26, 2017.
Article de Anglais | MEDLINE | ID: mdl-28469563

RÉSUMÉ

Although motor control has been extensively studied, most research involving neural recordings has focused on primary motor cortex, pre-motor cortex, supplementary motor area, and cerebellum. These regions are involved during normal movements, however, associative cortices and hippocampus are also likely involved during perturbed movements as one must detect the unexpected disturbance, inhibit the previous motor plan, and create a new plan to compensate. Minimal data is available on these brain regions during such "robust" movements. Here, epileptic patients implanted with intracerebral electrodes performed reaching movements while experiencing occasional unexpected force perturbations allowing study of the fronto-parietal, limbic and hippocampal network at unprecedented high spatial, and temporal scales. Areas including orbitofrontal cortex (OFC) and hippocampus showed increased activation during perturbed trials. These results, coupled with a visual novelty control task, suggest the hippocampal MTL-P300 novelty response is modality independent, and that the OFC is involved in modifying motor plans during robust movement.


Sujet(s)
Cartographie cérébrale , Cortex cérébral/physiopathologie , Potentiels évoqués visuels/physiologie , Hippocampe/physiopathologie , Troubles de la motricité/anatomopathologie , Adulte , Électroencéphalographie , Épilepsie/complications , Femelle , Humains , Imagerie par résonance magnétique , Mâle , Adulte d'âge moyen , Troubles de la motricité/étiologie , Voies nerveuses/physiopathologie , Tests neuropsychologiques , Stimulation lumineuse , Facteurs temps , Jeune adulte
16.
J Virol ; 91(4)2017 02 15.
Article de Anglais | MEDLINE | ID: mdl-27928002

RÉSUMÉ

Our previous work has shown that antigens adjuvanted with ligands specific for Toll-like receptor 4 (TLR4) and TLR7/8 encapsulated in poly(lactic-co-glycolic) acid (PLGA)-based nanoparticles (NPs) induce robust and durable immune responses in mice and macaques. We investigated the efficacy of these NP adjuvants in inducing protective immunity against simian immunodeficiency virus (SIV). Rhesus macaques (RMs) were immunized with NPs containing TLR4 and TLR7/8 agonists mixed with soluble recombinant SIVmac239-derived envelope (Env) gp140 and Gag p55 (protein) or with virus-like particles (VLPs) containing SIVmac239 Env and Gag. NP-adjuvanted vaccines induced robust innate responses, antigen-specific antibody responses of a greater magnitude and persistence, and enhanced plasmablast responses compared to those achieved with alum-adjuvanted vaccines. NP-adjuvanted vaccines induced antigen-specific, long-lived plasma cells (LLPCs), which persisted in the bone marrow for several months after vaccination. NP-adjuvanted vaccines induced immune responses that were associated with enhanced protection against repeated low-dose, intravaginal challenges with heterologous SIVsmE660 in animals that carried TRIM5α restrictive alleles. The protection induced by immunization with protein-NP correlated with the prechallenge titers of Env-specific IgG antibodies in serum and vaginal secretions. However, no such correlate was apparent for immunization with VLP-NP or alum as the adjuvant. Transcriptional profiling of peripheral blood mononuclear cells isolated within the first few hours to days after primary vaccination revealed that NP-adjuvanted vaccines induced a molecular signature similar to that induced by the live attenuated yellow fever viral vaccine. This systems approach identified early blood transcriptional signatures that correlate with Env-specific antibody responses in vaginal secretions and protection against infection. These results demonstrate the adjuvanticity of the NP adjuvant in inducing persistent and protective antibody responses against SIV in RMs with implications for the design of vaccines against human immunodeficiency virus (HIV). IMPORTANCE: The results of the RV144 HIV vaccine trial, which demonstrated a rapid waning of protective immunity with time, have underscored the need to develop strategies to enhance the durability of protective immune responses. Our recent work in mice has highlighted the capacity of nanoparticle-encapsulated TLR ligands (NP) to induce potent and durable antibody responses that last a lifetime in mice. In the present study, we evaluated the ability of these NP adjuvants to promote robust and durable protective immune responses against SIV in nonhuman primates. Our results demonstrate that immunization of rhesus macaques with NP adjuvants mixed with soluble SIV Env or a virus-like particle form of Env (VLP) induces potent and durable Env-specific antibody responses in the serum and in vaginal secretions. These responses were superior to those induced by alum adjuvant, and they resulted in enhanced protection against a low-dose intravaginal challenge with a heterologous strain of SIV in animals with TRIM5a restrictive alleles. These results highlight the potential for such NP TLR L adjuvants in promoting robust and durable antibody responses against HIV in the next generation of HIV immunogens currently being developed.


Sujet(s)
Adjuvants immunologiques , Anticorps antiviraux/immunologie , Nanoparticules , Vaccins contre le SIDA simien/immunologie , Syndrome d'immunodéficience acquise du singe/immunologie , Virus de l'immunodéficience simienne/immunologie , Animaux , Antigènes viraux/immunologie , Lymphocytes T CD4+/immunologie , Lymphocytes T CD4+/métabolisme , Protéines de transport/métabolisme , Analyse de regroupements , Femelle , Analyse de profil d'expression de gènes , Calendrier vaccinal , Immunoglobuline G/immunologie , Ligands , Numération des lymphocytes , Plasmocytes/immunologie , Plasmocytes/métabolisme , Vaccins contre le SIDA simien/administration et posologie , Syndrome d'immunodéficience acquise du singe/métabolisme , Syndrome d'immunodéficience acquise du singe/mortalité , Syndrome d'immunodéficience acquise du singe/prévention et contrôle , Récepteur de type Toll-4/métabolisme , Protéines de l'enveloppe virale/immunologie
17.
Brain Stimul ; 10(1): 126-138, 2017.
Article de Anglais | MEDLINE | ID: mdl-27839724

RÉSUMÉ

BACKGROUND: The motor thalamus is a key nodal point in the pallidothalamocortical "motor" circuit, which has been implicated in the pathogenesis of Parkinson's disease (PD) and other movement disorders. Although a critical structure in the motor circuit, the role of the motor thalamus in mediating the therapeutic effects of deep brain stimulation (DBS) of the internal segment of the globus pallidus (GPi) is not fully understood. OBJECTIVE: To characterize the changes in neuronal activity in the pallidal (ventralis lateralis pars oralis (VLo) and ventralis anterior (VA)) and cerebellar (ventralis posterior lateralis pars oralis (VPLo)) receiving areas of the motor thalamus during therapeutic GPi DBS. METHODS: Neuronal activity from the VA/VLo (n = 134) and VPLo (n = 129) was recorded from two non-human primates made parkinsonian using the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. For each isolated unit, one minute of data was recorded before, during and after DBS; a pulse width of 90 µs and a frequency of 135 Hz were used for DBS to replicate commonly used clinical settings. Stimulation amplitude was determined based on the parameters required to improve motor signs. Severity of motor signs was assessed using the UPDRS modified for nonhuman primates. Discharge rate, presence and characteristics of bursts, and oscillatory activity were computed and compared across conditions (pre-, during, and post-stimulation). RESULTS: Neurons in both the pallidal and cerebellar receiving areas demonstrated significant changes in their pattern of activity during therapeutic GPi DBS. A majority of the neurons in each nucleus were inhibited during DBS (VA/VLo: 47% and VPLo: 49%), while a smaller subset was excited (VA/VLo: 21% and VPLo: 17%). Bursts changed in structure, becoming longer in duration and both intra-burst and inter-spike intervals and variability were increased in both subnuclei. High frequency oscillatory activity was significantly increased during stimulation with 33% of VA/VLo (likelihood ratio: p < 0.0001) and 34% of VPLo (p < 0.0001) neurons entrained to the stimulation pulse train. CONCLUSIONS: Therapeutic GPi DBS produced a significant change in neuronal activity in both pallidal and cerebellar receiving areas of the motor thalamus. DBS suppressed activity in the majority of neurons, changed the structure of bursting activity and locked the neuronal response of one-third of cells to the stimulation pulse, leading to an increase in the power of gamma oscillations. These data support the hypothesis that stimulation activates output from the stimulated structure and that GPi DBS produces network-wide changes in neuronal activity that includes both the pallidal and cerebellar thalamo-cortical circuits.


Sujet(s)
Stimulation cérébrale profonde/méthodes , Globus pallidus/physiologie , Neurones/physiologie , Syndromes parkinsoniens/physiopathologie , Syndromes parkinsoniens/thérapie , Thalamus/physiologie , Potentiels d'action/physiologie , Animaux , Cervelet/physiologie , Femelle , Macaca mulatta , Primates
18.
Protist ; 167(2): 106-20, 2016 04.
Article de Anglais | MEDLINE | ID: mdl-26927496

RÉSUMÉ

Arranging organisms into functional groups aids ecological research by grouping organisms (irrespective of phylogenetic origin) that interact with environmental factors in similar ways. Planktonic protists traditionally have been split between photoautotrophic "phytoplankton" and phagotrophic "microzooplankton". However, there is a growing recognition of the importance of mixotrophy in euphotic aquatic systems, where many protists often combine photoautotrophic and phagotrophic modes of nutrition. Such organisms do not align with the traditional dichotomy of phytoplankton and microzooplankton. To reflect this understanding, we propose a new functional grouping of planktonic protists in an eco-physiological context: (i) phagoheterotrophs lacking phototrophic capacity, (ii) photoautotrophs lacking phagotrophic capacity, (iii) constitutive mixotrophs (CMs) as phagotrophs with an inherent capacity for phototrophy, and (iv) non-constitutive mixotrophs (NCMs) that acquire their phototrophic capacity by ingesting specific (SNCM) or general non-specific (GNCM) prey. For the first time, we incorporate these functional groups within a foodweb structure and show, using model outputs, that there is scope for significant changes in trophic dynamics depending on the protist functional type description. Accordingly, to better reflect the role of mixotrophy, we recommend that as important tools for explanatory and predictive research, aquatic food-web and biogeochemical models need to redefine the protist groups within their frameworks.


Sujet(s)
Eucaryotes/classification , Chaine alimentaire , Phytoplancton/classification , Zooplancton/classification , Animaux , Métabolisme énergétique/physiologie , Eucaryotes/métabolisme , Eucaryotes/physiologie , Processus phototrophes , Phylogenèse , Phytoplancton/métabolisme , Phytoplancton/physiologie , Zooplancton/métabolisme , Zooplancton/physiologie
19.
J Vasc Interv Radiol ; 22(3): 265-78, 2011 Mar.
Article de Anglais | MEDLINE | ID: mdl-21353979
20.
Int J Offender Ther Comp Criminol ; 54(5): 803-28, 2010 Oct.
Article de Anglais | MEDLINE | ID: mdl-20223913

RÉSUMÉ

This systematic review assessed the validity of screening instruments to identify the risk of suicide and self-harm behaviour in offenders. A search of 11 electronic databases and grey literature resulted in the inclusion of five studies. The five studies revealed four screening instruments, including the Suicide Checklist, the Suicide Probability Scale, Suicide Concerns for Offenders in Prison Environment (SCOPE), and the Suicide Potential Scale. Two instruments, SCOPE and Suicide Potential Scale, shared promising levels of sensitivity and specificity. The reporting of information was generally varied across items on the Standards for the Reporting of Diagnostic accuracy (STARD). Research is needed to assess the predictive validity of tools for offender populations in the identification of those at risk, particularly those in probation and community settings.


Sujet(s)
Dépistage de masse , Prisonniers/psychologie , Comportement auto-agressif/prévention et contrôle , Comportement auto-agressif/psychologie , Prévention du suicide , Suicide/psychologie , Adulte , Liste de contrôle , Femelle , Humains , Mâle , Facteurs de risque , Enquêtes et questionnaires
SÉLECTION CITATIONS
DÉTAIL DE RECHERCHE
...